Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 9, 2013
Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice
John R Walker, Reynand Pacoma, James Watson, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2008
Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase
Wooyoung Hur, Anastasia Velentza, Sungjoon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2012
A sulfated carbohydrate epitope inhibits axon regeneration after injury
Joshua M Brown, Jiang Xia, BinQuan Zhuang, et al.
Journal of Medicinal Chemistry
|
July 20, 2016
Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers
Gérald Lelais, Robert Epple, Thomas H Marsilje, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 30, 2003
Genome-scale functional profiling of the mammalian AP-1 signaling pathway
Sumit K Chanda, Suhaila White, Anthony P Orth, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 9, 2013
Enhanced proteolytic clearance of plasma Aβ by peripherally administered neprilysin does not result in reduced levels of brain Aβ in mice
John R Walker, Reynand Pacoma, James Watson, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 1, 2008
Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase
Wooyoung Hur, Anastasia Velentza, Sungjoon Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2012
A sulfated carbohydrate epitope inhibits axon regeneration after injury
Joshua M Brown, Jiang Xia, BinQuan Zhuang, et al.
Journal of Medicinal Chemistry
|
July 20, 2016
Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers
Gérald Lelais, Robert Epple, Thomas H Marsilje, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 30, 2003
Genome-scale functional profiling of the mammalian AP-1 signaling pathway
Sumit K Chanda, Suhaila White, Anthony P Orth, et al.
Page
of 3